$EFSI
EAGLE FINANCIAL SERVICES INC

2021 Q1 Form 10-K Financial Statement

#000156459021016594 Filed on March 30, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 2019 Q4
Revenue $10.02M $38.91M $9.027M
YoY Change 9.98% 9.74% 8.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $252.0K $1.028M $350.0K
YoY Change -2.33% 7.42% 20.69%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $487.0K $3.281M
YoY Change -55.81% -22.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.441M $13.31M $3.396M
YoY Change 17.96% 15.03% 35.68%
Income Tax $579.0K $2.136M $570.0K
% Of Pretax Income 16.83% 16.05% 16.78%
Net Earnings $2.862M $11.17M $2.831M
YoY Change 17.25% 14.48% 36.04%
Net Earnings / Revenue 28.57% 28.71% 31.36%
Basic Earnings Per Share $0.84 $3.27 $0.83
Diluted Earnings Per Share $0.84 $3.27 $0.83
COMMON SHARES
Basic Shares Outstanding 3.430M 3.418M 3.433M shares
Diluted Shares Outstanding 3.427M 3.418M

Balance Sheet

Concept 2021 Q1 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $87.15M $33.66M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.82M $22.80M $19.30M
YoY Change -1.86% 18.13% 1.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.185B $1.130B $877.3M
YoY Change 31.83% 28.83% 9.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $4.000M $4.000M
YoY Change -4.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.000M $4.000M
YoY Change -4.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.900M $8.000M $9.500M
YoY Change 61.22% -15.79% 35.71%
Total Long-Term Liabilities $7.900M $8.000M $9.500M
YoY Change 61.22% -15.79% 35.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.000M $4.000M
Total Long-Term Liabilities $7.900M $8.000M $9.500M
Total Liabilities $1.080B $1.025B $781.0M
YoY Change 35.14% 31.25% 9.69%
SHAREHOLDERS EQUITY
Retained Earnings $84.46M $74.91M
YoY Change 10.47% 9.22%
Common Stock $8.495M $8.529M
YoY Change 0.34% -0.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $105.1M $105.1M $96.33M
YoY Change
Total Liabilities & Shareholders Equity $1.185B $1.130B $877.3M
YoY Change 31.83% 28.83% 9.72%

Cashflow Statement

Concept 2021 Q1 2020 2019 Q4
OPERATING ACTIVITIES
Net Income $2.862M $11.17M $2.831M
YoY Change 17.25% 14.48% 36.04%
Depreciation, Depletion And Amortization $252.0K $1.028M $350.0K
YoY Change -2.33% 7.42% 20.69%
Cash From Operating Activities $3.881M $11.01M $3.060M
YoY Change 104.59% -3.01% -14.04%
INVESTING ACTIVITIES
Capital Expenditures $349.0K $456.0K -$190.0K
YoY Change 149.29% -65.3% -195.0%
Acquisitions
YoY Change
Other Investing Activities -$50.37M -$201.0M -$33.41M
YoY Change 74.11% 254.72% 355.8%
Cash From Investing Activities -$50.72M -$201.5M -$33.59M
YoY Change 74.48% 247.48% 371.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 54.07M 236.7M 25.04M
YoY Change 226.56% 282.19% 185.84%
NET CHANGE
Cash From Operating Activities 3.881M 11.01M 3.060M
Cash From Investing Activities -50.72M -201.5M -33.59M
Cash From Financing Activities 54.07M 236.7M 25.04M
Net Change In Cash 7.230M 46.26M -5.490M
YoY Change -168.12% 202.24% -205.78%
FREE CASH FLOW
Cash From Operating Activities $3.881M $11.01M $3.060M
Capital Expenditures $349.0K $456.0K -$190.0K
Free Cash Flow $3.532M $10.55M $3.250M
YoY Change 101.02% 5.14% -3.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
7014000
CY2020 efsi Period Intereston Mortgage Loans Discontinued
PeriodInterestonMortgageLoansDiscontinued
P120D
CY2020 efsi Maximum Age Benefits Can Be Reduced Or Forfeited Due To Employment Termination
MaximumAgeBenefitsCanBeReducedOrForfeitedDueToEmploymentTermination
P65Y
CY2020 efsi Number Of Preceding Years Undistributed Net Income
NumberOfPrecedingYearsUndistributedNetIncome
P3Y
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020Q2 dei Entity Public Float
EntityPublicFloat
67812259
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
12644000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
10920000
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
67054000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
22487000
CY2020Q4 us-gaap Federal Funds Sold
FederalFundsSold
222000
CY2019Q4 us-gaap Federal Funds Sold
FederalFundsSold
252000
CY2020Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
79920000
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
33659000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
164955000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
165003000
CY2020Q4 us-gaap Restricted Investments
RestrictedInvestments
1267000
CY2019Q4 us-gaap Restricted Investments
RestrictedInvestments
1197000
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
836334000
CY2019Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
644760000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7096000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4973000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
829238000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
639787000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18725000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19297000
CY2020Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
607000
CY2019Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
183000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3035000
CY2020 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
588000
CY2020 us-gaap Dividend Income Operating
DividendIncomeOperating
76000
CY2019 us-gaap Dividend Income Operating
DividendIncomeOperating
70000
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
P.O. Box 391
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Berryville
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22611
CY2020 dei City Area Code
CityAreaCode
(540)
CY2020 dei Local Phone Number
LocalPhoneNumber
955-2510
CY2020 dei Security12g Title
Security12gTitle
Common Stock, Par Value $2.50
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3429686
CY2019 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-7000
CY2020 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
112000
CY2019 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
297000
CY2019 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
4000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
164955000
CY2019 us-gaap Noninterest Income
NoninterestIncome
7759000
CY2020Q4 us-gaap Other Assets
OtherAssets
35440000
CY2019Q4 us-gaap Other Assets
OtherAssets
18194000
CY2020Q4 us-gaap Assets
Assets
1130152000
CY2019Q4 us-gaap Assets
Assets
877320000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
407576000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
269171000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
476864000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
364175000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
128658000
CY2019Q4 us-gaap Time Deposits
TimeDeposits
138198000
CY2020Q4 us-gaap Deposits Domestic
DepositsDomestic
1013098000
CY2019Q4 us-gaap Deposits Domestic
DepositsDomestic
771544000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
11980000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
9450000
CY2020Q4 us-gaap Liabilities
Liabilities
1025078000
CY2019Q4 us-gaap Liabilities
Liabilities
780994000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3405035
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3405035
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20928
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3430103
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3430103
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18488
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8460000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8529000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10811000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11406000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
82524000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74909000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3279000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1482000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
105074000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
96326000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1130152000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
877320000
CY2019 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
31138000
CY2020 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
1000
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
38908000
CY2019 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
35454000
CY2020 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3256000
CY2019 us-gaap Interest Expense Deposits
InterestExpenseDeposits
4193000
CY2019 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
31000
CY2020 efsi Interest Expense Borrowings1
InterestExpenseBorrowings1
25000
CY2019 efsi Interest Expense Borrowings1
InterestExpenseBorrowings1
15000
CY2020 us-gaap Interest Expense
InterestExpense
3281000
CY2019 us-gaap Interest Expense
InterestExpense
4239000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35627000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31215000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1457000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
629000
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
34170000
CY2019 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
30586000
CY2020 efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
1398000
CY2019 efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
1380000
CY2020 efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
920000
CY2019 efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
1187000
CY2020 efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
4757000
CY2019 efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
4893000
CY2020 efsi Gain Loss On Sale Of Bank Premises And Equipment
GainLossOnSaleOfBankPremisesAndEquipment
5000
CY2019 efsi Gain Loss On Sale Of Bank Premises And Equipment
GainLossOnSaleOfBankPremisesAndEquipment
137000
CY2020 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
687000
CY2020 efsi Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
310000
CY2019 efsi Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
-48000
CY2020 us-gaap Noninterest Income Other
NoninterestIncomeOther
502000
CY2019 us-gaap Noninterest Income Other
NoninterestIncomeOther
217000
CY2020 us-gaap Noninterest Income
NoninterestIncome
8579000
CY2019 us-gaap Noninterest Income
NoninterestIncome
7759000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18074000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
15025000
CY2020 us-gaap Occupancy Net
OccupancyNet
1592000
CY2019 us-gaap Occupancy Net
OccupancyNet
1611000
CY2020 us-gaap Equipment Expense
EquipmentExpense
988000
CY2019 us-gaap Equipment Expense
EquipmentExpense
857000
CY2020 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
707000
CY2019 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
868000
CY2020 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
144000
CY2019 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
172000
CY2020 efsi Atm Network Fees
AtmNetworkFees
1009000
CY2019 efsi Atm Network Fees
AtmNetworkFees
1141000
CY2020 efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
9000
CY2019 efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
76000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
143000
CY2019 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-443000
CY2020 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
221000
CY2019 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
105000
CY2020 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
679000
CY2019 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
459000
CY2020 efsi Bank Franchise Tax
BankFranchiseTax
705000
CY2019 efsi Bank Franchise Tax
BankFranchiseTax
656000
CY2020 us-gaap Professional Fees
ProfessionalFees
1120000
CY2019 us-gaap Professional Fees
ProfessionalFees
1057000
CY2020 efsi Dataprocessingfees
Dataprocessingfees
1657000
CY2019 efsi Dataprocessingfees
Dataprocessingfees
1275000
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2679000
CY2019 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3031000
CY2020 us-gaap Noninterest Expense
NoninterestExpense
29441000
CY2019 us-gaap Noninterest Expense
NoninterestExpense
26776000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13308000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11569000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2136000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1810000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
11172000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
9759000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.27
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.27
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.84
CY2020 us-gaap Net Income Loss
NetIncomeLoss
11172000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
9759000
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-5000
CY2019 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
0
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
25000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
484000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
807000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1822000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3035000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1797000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12969000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12794000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
87599000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
516000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
9759000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3035000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1397000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
942000
CY2019 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
18150
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
562000
CY2019 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
14176
CY2019 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
441000
CY2019 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
4064
CY2019 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
138000
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
53988
CY2019 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-1771000
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2019 us-gaap Dividends Common Stock
DividendsCommonStock
3437000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
96326000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
11172000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1797000
CY2020 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
19238
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
604000
CY2020 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
13239
CY2020 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
359000
CY2020 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
7204
CY2020 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
227000
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
67189
CY2020 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-1854000
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.04
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
3557000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
105074000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
11172000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
9759000
CY2020 us-gaap Depreciation
Depreciation
1028000
CY2019 us-gaap Depreciation
Depreciation
957000
CY2020 efsi Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
411000
CY2019 efsi Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
358000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1457000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
629000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
143000
CY2019 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-443000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
137000
CY2020 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-5000
CY2020 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
687000
CY2019 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-7000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
604000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
562000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-801000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-487000
CY2020 efsi Bank Owned Life Insurance Income Expense Net
BankOwnedLifeInsuranceIncomeExpenseNet
310000
CY2019 efsi Bank Owned Life Insurance Income Expense Net
BankOwnedLifeInsuranceIncomeExpenseNet
-48000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-471000
CY2020 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-1459000
CY2019 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-1339000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11006000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11348000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
52360000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24604000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
28323000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
12350000
CY2020 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
78443000
CY2019 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
54310000
CY2020 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
12000000
CY2020 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
191411000
CY2019 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
40211000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201474000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57982000
CY2020 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
251094000
CY2019 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
45384000
CY2020 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-9540000
CY2019 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
23056000
CY2019 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
-1871000
CY2020 efsi Issuance Of Common Stock Employee Benefit Plan
IssuanceOfCommonStockEmployeeBenefitPlan
227000
CY2019 efsi Issuance Of Common Stock Employee Benefit Plan
IssuanceOfCommonStockEmployeeBenefitPlan
138000
CY2020 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
2125000
CY2019 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
425000
CY2020 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2195000
CY2019 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
452000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
279000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
456000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1314000
CY2020 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
160000
CY2019 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
631000
CY2020 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
58000
CY2019 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
16000
CY2020 efsi Paymentsfor Retirement Of Common Stock
PaymentsforRetirementOfCommonStock
1854000
CY2019 efsi Paymentsfor Retirement Of Common Stock
PaymentsforRetirementOfCommonStock
1771000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3198000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2996000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
236729000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61940000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46261000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15306000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33659000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18353000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79920000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33659000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3351000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
4198000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
2618000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2306000
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3842000
CY2020 us-gaap Other Postretirement Benefits Expense Reversal Of Expense Noncash
OtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
-30000
CY2020 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
503000
CY2019 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
1167000
CY2020 us-gaap Stock Issued1
StockIssued1
359000
CY2019 us-gaap Stock Issued1
StockIssued1
441000
CY2020 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
549000
CY2019 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
3745000
CY2020Q4 efsi Consolidated Financial Ownership Wholly Owned Subsidiary Percentage
ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage
1
CY2020 efsi Period Intereston Commercial Loans Discontinued
PeriodInterestonCommercialLoansDiscontinued
P90D
CY2020 efsi Credit Card Loans Charged Off After Past Due
CreditCardLoansChargedOffAfterPastDue
P180D
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks by Loan Portfolio Segments</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">One-to-Four-Family Residential Real Estate Lending</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Residential mortgage loans generally are made on the basis of the borrower’s ability to make repayment from employment and other income and are secured by real estate whose value tends to be readily ascertainable. As part of the application process, information is gathered concerning income, employment and credit history of the applicant. The valuation of residential collateral is provided by independent fee appraisers who have been approved by the Bank’s Directors Loan Committee.</p> <p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Commercial Real Estate Lending</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial real estate lending entails significant additional risk as compared with residential mortgage lending. Commercial real estate loans typically involve larger loan balances concentrated with single borrowers or groups of related borrowers. Additionally, the repayment of loans secured by income producing properties is typically dependent on the successful operation of a business or a real estate project and thus may be subject, to a greater extent, to adverse conditions in the real estate market or the economy, in general.</p> <p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Construction and Land Development Lending</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are two characteristics of construction lending which impact its overall risk as compared to residential mortgage lending. First, there is more concentration risk due to the extension of a large loan balance through several lines of credit to a single developer or contractor. Second, there is more collateral risk due to the fact that loan funds are provided to the borrower based upon the estimated value of the collateral after completion. This could cause an inaccurate estimate of the amount needed to complete construction or an excessive loan-to-value ratio. To mitigate the risks associated with construction lending, the Bank generally limits loan amounts to 80% of the estimated appraised value of the finished home.</p> <p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Commercial and Industrial Lending</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial business loans generally have more risk than residential mortgage loans, but have higher yields. To manage these risks, the Bank generally obtains appropriate collateral and personal guarantees from the borrower’s principal owners and monitors the financial condition of the borrower. Commercial business loans typically are made on the basis of the borrower’s ability to make repayment from cash flow from its business and are secured by business assets, such as commercial real estate, accounts receivable, equipment and inventory. As a result, the availability of funds for the repayment of commercial business loans is substantially dependent on the success of the business itself. Furthermore, the collateral for commercial business loans may depreciate over time and generally cannot be appraised with as much precision as residential real estate.</p> <p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Consumer Lending</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consumer loans generally entail greater risk than residential mortgage loans, particularly in the case of consumer loans which are unsecured or secured by rapidly depreciable assets such as automobiles. In such cases, any repossessed collateral on a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Paycheck Protection Program Loans</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020, the Company participated in the Paycheck Protection Program (PPP).  The PPP commenced subsequent to the passage of the Coronavirus Aid, Relief and Economic Security("CARES") Act in March 2020 and was later expanded by the Paycheck Protection Program and Health Care Enhancement Act of April 2020. The PPP was designed to provide U.S. small businesses with cash-flow assistance during the COVID-19 pandemic through loans that are fully guaranteed by the Small Business Administration (SBA) which may be forgiven upon satisfaction of certain criteria. As of December 31, 2020, the Company had 911 PPP loans with outstanding balances totaling $81.3 million. As compensation for originating the loans, the Company received lender processing fees from the SBA, which were deferred, along with the related loan origination costs. These net fees are being accreted to interest income over the remaining contractual lives of the loans. Upon forgiveness of a PPP loan and repayment by the SBA, which may be prior to the loan's maturity, the remainder of any unrecognized net fees are recognized in interest income.  The Company has continued to participate in the newest round of the PPP during the first quarter of 2021.  Our outstanding PPP loans were included in the commercial and industrial segment at December 31, 2020, and their underlying guarantees were considered in the determination of the allowance for loan losses as discussed below.</p>
CY2020Q4 efsi Percentage Limit Of Estimated Appraised Value Of Home
PercentageLimitOfEstimatedAppraisedValueOfHome
0.80
CY2020Q4 efsi Common Stock Shares Authorized Compensation Plan
CommonStockSharesAuthorizedCompensationPlan
500000
CY2020Q4 efsi Percentage To Represent More Likely Than Not
PercentageToRepresentMoreLikelyThanNot
0.50
CY2020 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
67189
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications have been made to the 2019 financial statements to conform to reporting for 2020.  The results of the reclassifications are not considered material and had no effect on prior years' net income or shareholders' equity.</p>
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3417543
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3438410
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3417543
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3438410
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:14pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The material estimate that is particularly susceptible to significant change in the near term relates to the determination of the allowance for loan losses.</p>
CY2020Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
150000
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
27.60
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
53988
CY2019 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
32.79
CY2020Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
121425
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
160827000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4174000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
46000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
164955000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
163181000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2187000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
365000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
165003000
CY2020Q4 us-gaap Restricted Investments
RestrictedInvestments
1267000
CY2019Q4 us-gaap Restricted Investments
RestrictedInvestments
1197000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
751000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
760000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
8587000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
8879000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
32281000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
34056000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
119208000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
121260000
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
160827000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
164955000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
28300000
CY2020 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
687000
CY2020 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
12400000
CY2019 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
37000
CY2019 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
44000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
12014000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
46000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
49000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
12014000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
46000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
28102000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
316000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
8191000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
36293000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
365000
CY2020Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
3
CY2019Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
28
CY2020Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
3100000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
835649000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
645207000
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
685000
CY2019Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-447000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7096000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4973000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
829238000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
639787000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5456000
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1457000
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
629000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1131000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
201000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
465000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1313000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7096000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1862000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
833787000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
835649000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4754000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3789000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
641418000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
645207000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2185000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
465000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1131000
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1457000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7096000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
72000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7024000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
835649000
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7768000
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8835000
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7785000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
72000
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
8025000
CY2020 efsi Troubled Debt Restructuring Modifications By Granting Concession Number Of Contracts
TroubledDebtRestructuringModificationsByGrantingConcessionNumberOfContracts
5
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
827881000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5456000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1313000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
201000
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
629000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
300000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4673000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
645207000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7403000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
637804000
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
186000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8381000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7420000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
300000
CY2019 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
7685000
CY2019 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
301000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
814328000
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
635666000
CY2020 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
17
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3300000
CY2019 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
18
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3000000.0
CY2020Q4 efsi Financing Receivable Modifications Nonaccrual Numberof Contracts
FinancingReceivableModificationsNonaccrualNumberofContracts
3
CY2020Q4 efsi Financing Receivable Modifications Nonaccrual Recorded Investment
FinancingReceivableModificationsNonaccrualRecordedInvestment
796000
CY2019Q4 efsi Financing Receivable Modifications Nonaccrual Numberof Contracts
FinancingReceivableModificationsNonaccrualNumberofContracts
4
CY2019Q4 efsi Financing Receivable Modifications Nonaccrual Recorded Investment
FinancingReceivableModificationsNonaccrualRecordedInvestment
401000
CY2020Q4 efsi Number Of Deferral Loans Of Interest And Principal Payments
NumberOfDeferralLoansOfInterestAndPrincipalPayments
255
CY2020Q4 efsi Number Of Loans Making Payment After Deferral Option Passed
NumberOfLoansMakingPaymentAfterDeferralOptionPassed
241
CY2020Q4 efsi Finance Receivable Modifications Amounts
FinanceReceivableModificationsAmounts
128700000
CY2020 efsi Troubled Debt Restructuring Modifications Number Of Contracts
TroubledDebtRestructuringModificationsNumberOfContracts
5
CY2020 efsi Troubled Debt Restructuring Modifications Pre Modification Recorded Investment
TroubledDebtRestructuringModificationsPreModificationRecordedInvestment
1629000
CY2020 efsi Troubled Debt Restructuring Modifications Post Modification Recorded Investment
TroubledDebtRestructuringModificationsPostModificationRecordedInvestment
1633000
CY2020Q4 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
163000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
23000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33500000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33088000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14775000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13791000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18725000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19297000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
407576000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
269171000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
132249000
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
102337000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
207837000
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
154133000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
136778000
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
107705000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
476864000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
364175000
CY2020Q4 efsi Time Deposits Lessthan250000
TimeDepositsLessthan250000
59621000
CY2019Q4 efsi Time Deposits Lessthan250000
TimeDepositsLessthan250000
59094000
CY2020Q4 efsi Time Deposits250000or More
TimeDeposits250000orMore
69037000
CY2019Q4 efsi Time Deposits250000or More
TimeDeposits250000orMore
79104000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
128658000
CY2019Q4 us-gaap Time Deposits
TimeDeposits
138198000
CY2020Q4 us-gaap Deposits Domestic
DepositsDomestic
1013098000
CY2019Q4 us-gaap Deposits Domestic
DepositsDomestic
771544000
CY2020Q4 efsi Reciprocal Money Market Accounts Domestic
ReciprocalMoneyMarketAccountsDomestic
34600000
CY2019Q4 efsi Reciprocal Money Market Accounts Domestic
ReciprocalMoneyMarketAccountsDomestic
27000000.0
CY2020Q4 us-gaap Time Deposits
TimeDeposits
128658000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
705000
CY2020Q4 efsi Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
843000
CY2020Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
117375000
CY2020Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
6484000
CY2020Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
2031000
CY2020Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
1391000
CY2020Q4 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
1214000
CY2020Q4 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
70000
CY2019Q4 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
135000
CY2020 efsi Federal Funds Purchased Activity For Year Average Balance Of Agreements Outstanding
FederalFundsPurchasedActivityForYearAverageBalanceOfAgreementsOutstanding
1000
CY2019 efsi Federal Funds Purchased Activity For Year Average Balance Of Agreements Outstanding
FederalFundsPurchasedActivityForYearAverageBalanceOfAgreementsOutstanding
1074000
CY2020 efsi Federal Funds Purchased Activity For Year Average Interest Rate For Year
FederalFundsPurchasedActivityForYearAverageInterestRateForYear
0.0061
CY2019 efsi Federal Funds Purchased Activity For Year Average Interest Rate For Year
FederalFundsPurchasedActivityForYearAverageInterestRateForYear
0.0291
CY2019 efsi Federal Funds Purchased Activity For Year Maximum Outstanding At Any Month End
FederalFundsPurchasedActivityForYearMaximumOutstandingAtAnyMonthEnd
10780000
CY2020 efsi Federal Funds Purchased Activity For Year Gross Lines Of Credit
FederalFundsPurchasedActivityForYearGrossLinesOfCredit
28000000
CY2019 efsi Federal Funds Purchased Activity For Year Gross Lines Of Credit
FederalFundsPurchasedActivityForYearGrossLinesOfCredit
28000000
CY2020 efsi Federal Funds Purchased Activity For Year Unused Lines Of Credit
FederalFundsPurchasedActivityForYearUnusedLinesOfCredit
28000000
CY2019 efsi Federal Funds Purchased Activity For Year Unused Lines Of Credit
FederalFundsPurchasedActivityForYearUnusedLinesOfCredit
28000000
CY2020Q4 us-gaap Federal Home Loan Bank Advances
FederalHomeLoanBankAdvances
0
CY2019Q4 us-gaap Federal Home Loan Bank Advances
FederalHomeLoanBankAdvances
0
CY2020Q4 efsi Federal Home Loan Bank Irrevocable Letterof Credit
FederalHomeLoanBankIrrevocableLetterofCredit
50000000.0
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
1490000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
1044000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
100000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
91000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
21000
CY2020Q4 efsi Deferred Tax Assets Home Equity Origination Costs
DeferredTaxAssetsHomeEquityOriginationCosts
50000
CY2019Q4 efsi Deferred Tax Assets Home Equity Origination Costs
DeferredTaxAssetsHomeEquityOriginationCosts
52000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
76000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
51000
CY2020Q4 efsi Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
864000
CY2019Q4 efsi Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
773000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
24000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1294000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
23000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2625000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2057000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
713000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
22128
CY2019Q4 efsi Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
759000
CY2020Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
867000
CY2019Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
383000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2423000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1847000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
202000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
210000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2607000
CY2020 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-471000
CY2019 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
516000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2136000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1810000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2795000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2429000
CY2020 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
193000
CY2019 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
260000
CY2020 efsi Effective Income Tax Rate Reconciliation Tax Exempt Income Life Insurance Amount
EffectiveIncomeTaxRateReconciliationTaxExemptIncomeLifeInsuranceAmount
57000
CY2019 efsi Effective Income Tax Rate Reconciliation Tax Exempt Income Life Insurance Amount
EffectiveIncomeTaxRateReconciliationTaxExemptIncomeLifeInsuranceAmount
-15000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
439000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
379000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
30000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
5000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2136000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1810000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1605
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1565
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18488
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.39
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
16701
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.72
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.82
CY2020Q4 efsi Common Equity Tier One Capitalto Risk Weighted Assets
CommonEquityTierOneCapitaltoRiskWeightedAssets
0.1239
CY2020 efsi Deferred Compensation Arrangement Grant Date Fair Value Of Vested Restricted Stock
DeferredCompensationArrangementGrantDateFairValueOfVestedRestrictedStock
558000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
22488
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.69
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
19238
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
29.01
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
18150
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.16
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
450
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
31.03
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2551
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
30.28
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20928
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.98
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18488
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.39
CY2020 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
604000
CY2019 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
562000
CY2019 efsi Deferred Compensation Arrangement Grant Date Fair Value Of Vested Restricted Stock
DeferredCompensationArrangementGrantDateFairValueOfVestedRestrictedStock
547000
CY2020 efsi Deferred Compensation Arrangement Vest Date Fair Value Of Vested Restricted Stock
DeferredCompensationArrangementVestDateFairValueOfVestedRestrictedStock
561000
CY2019 efsi Deferred Compensation Arrangement Vest Date Fair Value Of Vested Restricted Stock
DeferredCompensationArrangementVestDateFairValueOfVestedRestrictedStock
556000
CY2020 efsi Deferred Compensation Arrangements Unrecognized Compensation Cost Related To Unvested Restricted Stock
DeferredCompensationArrangementsUnrecognizedCompensationCostRelatedToUnvestedRestrictedStock
184000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2020 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2020Q4 efsi Non Elective Safe Harbor Employer Contribution And Age Weighted Employer Contribution Percent
NonElectiveSafeHarborEmployerContributionAndAgeWeightedEmployerContributionPercent
0.03
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1500000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1100000
CY2020Q4 efsi Executive Supplemental Income Benefit Liability
ExecutiveSupplementalIncomeBenefitLiability
23000
CY2019Q4 efsi Executive Supplemental Income Benefit Liability
ExecutiveSupplementalIncomeBenefitLiability
30000
CY2020 efsi Executive Supplemental Income Benefit Expense
ExecutiveSupplementalIncomeBenefitExpense
29000
CY2019 efsi Executive Supplemental Income Benefit Expense
ExecutiveSupplementalIncomeBenefitExpense
21000
CY2019Q4 efsi Federal Reserve Bank Daily Average Required Balance
FederalReserveBankDailyAverageRequiredBalance
1700000
CY2020Q4 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
250000
CY2019Q4 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
250000
CY2020Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
78977000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17Y
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P20Y
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0334
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0362
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
287000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
261000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
16000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
16000
CY2020 us-gaap Lease Cost
LeaseCost
303000
CY2019 us-gaap Lease Cost
LeaseCost
277000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
239000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
319000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
321000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
324000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
327000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
346000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4039000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5676000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1563000
CY2016Q1 efsi Capital Conservation Buffer In Percentage
CapitalConservationBufferInPercentage
0.00625
CY2020 efsi Capital Conservation Buffer In Percentage Annual Increase
CapitalConservationBufferInPercentageAnnualIncrease
0.00625
CY2019Q1 efsi Capital Conservation Buffer In Percentage
CapitalConservationBufferInPercentage
0.025
CY2020 efsi Capital Conservation Buffer In Percentage
CapitalConservationBufferInPercentage
0.0529
CY2020Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
97825000
CY2020Q4 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
35540000
CY2020Q4 efsi Common Equity Tier One Capital For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneCapitalForCapitalAdequacyToRiskWeightedAssets
0.0450
CY2020Q4 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
51335000
CY2020Q4 efsi Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0650
CY2020Q4 us-gaap Capital
Capital
104957000
CY2020Q4 efsi Capital To Risk Weighted Assets1
CapitalToRiskWeightedAssets1
0.1329
CY2020Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
63182000
CY2020Q4 efsi Capital Required For Capital Adequacy To Risk Weighted Assets1
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets1
0.0800
CY2020Q4 efsi Capital Required To Be Well Capitalized To Risk Weighted Assets1
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets1
0.1000
CY2020Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
97825000
CY2020Q4 efsi Tier One Risk Based Capital To Risk Weighted Assets1
TierOneRiskBasedCapitalToRiskWeightedAssets1
0.1239
CY2020Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
47386000
CY2020Q4 efsi Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets1
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets1
0.0600
CY2020Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
63182000
CY2020Q4 efsi Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets1
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets1
0.0800
CY2020Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
97825000
CY2020Q4 efsi Tier One Leverage Capital To Average Assets1
TierOneLeverageCapitalToAverageAssets1
0.0906
CY2020Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
43213000
CY2020Q4 efsi Tier One Leverage Capital Required For Capital Adequacy To Average Assets1
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets1
0.0400
CY2020Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
54016000
CY2020Q4 efsi Tier One Leverage Capital Required To Be Well Capitalized To Average Assets1
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets1
0.0500
CY2019Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
90775000
CY2019Q4 efsi Common Equity Tier One Capitalto Risk Weighted Assets
CommonEquityTierOneCapitaltoRiskWeightedAssets
0.1365
CY2019Q4 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
29931000
CY2019Q4 efsi Common Equity Tier One Capital For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneCapitalForCapitalAdequacyToRiskWeightedAssets
0.0450
CY2019Q4 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
43234000
CY2019Q4 efsi Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0650
CY2019Q4 us-gaap Capital
Capital
95772000
CY2019Q4 efsi Capital To Risk Weighted Assets1
CapitalToRiskWeightedAssets1
0.1440
CY2019Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
53211000
CY2019Q4 efsi Capital Required For Capital Adequacy To Risk Weighted Assets1
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets1
0.0800
CY2019Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
66514000
CY2019Q4 efsi Capital Required To Be Well Capitalized To Risk Weighted Assets1
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets1
0.1000
CY2019Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
90775000
CY2019Q4 efsi Tier One Risk Based Capital To Risk Weighted Assets1
TierOneRiskBasedCapitalToRiskWeightedAssets1
0.1365
CY2019Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
39908000
CY2019Q4 efsi Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets1
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets1
0.0600
CY2019Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
53211000
CY2019Q4 efsi Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets1
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets1
0.0800
CY2019Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
90775000
CY2019Q4 efsi Tier One Leverage Capital To Average Assets1
TierOneLeverageCapitalToAverageAssets1
0.1061
CY2019Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
34216000
CY2019Q4 efsi Tier One Leverage Capital Required For Capital Adequacy To Average Assets1
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets1
0.0400
CY2019Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
42770000
CY2019Q4 efsi Tier One Leverage Capital Required To Be Well Capitalized To Average Assets1
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets1
0.0500
CY2020Q4 us-gaap Statutory Accounting Practices Statutory Amount Available For Dividend Payments
StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments
17700000
CY2020Q4 efsi Restricted Equity In Net Assets Of Bank
RestrictedEquityInNetAssetsOfBank
83400000
CY2020 efsi Funds Available For Loans Or Advances
FundsAvailableForLoansOrAdvances
10500000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
165003000
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
7465000
CY2016Q4 efsi Percentage Of Fair Market Value Purchase Additional Shares Common Stock
PercentageOfFairMarketValuePurchaseAdditionalSharesCommonStock
0.95
CY2020 efsi Financial Instruments Commitments To Extend Credit
FinancialInstrumentsCommitmentsToExtendCredit
27558000
CY2019 efsi Financial Instruments Commitments To Extend Credit
FinancialInstrumentsCommitmentsToExtendCredit
19939000
CY2020 efsi Financial Instruments Unfunded Commitments Under Lines Of Credit
FinancialInstrumentsUnfundedCommitmentsUnderLinesOfCredit
146202000
CY2019 efsi Financial Instruments Unfunded Commitments Under Lines Of Credit
FinancialInstrumentsUnfundedCommitmentsUnderLinesOfCredit
121609000
CY2020 efsi Financial Instruments Commercial And Standby Letters Of Credit
FinancialInstrumentsCommercialAndStandbyLettersOfCredit
8139000
CY2019 efsi Financial Instruments Commercial And Standby Letters Of Credit
FinancialInstrumentsCommercialAndStandbyLettersOfCredit
6132000
CY2020Q4 efsi Collateralized Letters Of Credit Outstanding
CollateralizedLettersOfCreditOutstanding
7800000
CY2020 efsi Excess Of Insurance Limits Held In Cash Accounts In Other Commercial Banks
ExcessOfInsuranceLimitsHeldInCashAccountsInOtherCommercialBanks
3700000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
5000
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
137000
CY2020 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
687000
CY2019 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-7000
CY2020 efsi Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
310000
CY2019 efsi Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
-48000
CY2020 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
502000
CY2019 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
217000
CY2020 us-gaap Noninterest Income
NoninterestIncome
8579000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9107000
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9661000
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10150000
CY2020Q4 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9990000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8102000
CY2020Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8005000
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9367000
CY2020Q4 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8696000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
1690000
CY2020Q2 us-gaap Noninterest Income
NoninterestIncome
2422000
CY2020Q3 us-gaap Noninterest Income
NoninterestIncome
2216000
CY2020Q4 us-gaap Noninterest Income
NoninterestIncome
2251000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
6875000
CY2020Q4 us-gaap Noninterest Expense
NoninterestExpense
8087000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2917000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3413000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4118000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2860000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2441000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
3406000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2506000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8593000
CY2019Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8750000
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9084000
CY2019Q4 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9027000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7430000
CY2019Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7433000
CY2019Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7835000
CY2019Q4 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7888000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
1844000
CY2019Q2 us-gaap Noninterest Income
NoninterestIncome
1878000
CY2019Q3 us-gaap Noninterest Income
NoninterestIncome
2219000
CY2019Q4 us-gaap Noninterest Income
NoninterestIncome
1818000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
6231000
CY2019Q2 us-gaap Noninterest Expense
NoninterestExpense
6824000
CY2019Q3 us-gaap Noninterest Expense
NoninterestExpense
7411000
CY2019Q4 us-gaap Noninterest Expense
NoninterestExpense
6310000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3043000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2487000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2643000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3396000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2571000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2126000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2231000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
2831000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000
CY2020 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
684000
CY2019 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
3835000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1482000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1553000
CY2020 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
2960000
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-7000
CY2020 efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
479000
CY2019 efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
807000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1797000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3035000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3279000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1482000
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
144000
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-1000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000
CY2018Q4 us-gaap Other Real Estate
OtherRealEstate
106000
CY2020 us-gaap Other Real Estate Additions
OtherRealEstateAdditions
441000
CY2019 us-gaap Other Real Estate Additions
OtherRealEstateAdditions
1151000
CY2020 efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
166000
CY2019 efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
192000
CY2020 us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
183000
CY2019 us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
1266000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
607000
CY2020Q4 efsi Other Real Estate Gross
OtherRealEstateGross
607000
CY2019Q4 efsi Other Real Estate Gross
OtherRealEstateGross
183000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
607000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000
CY2020Q4 efsi Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
1
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
68000
CY2019Q4 efsi Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
2
CY2019Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
334000
CY2020Q4 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
2800000
CY2019Q4 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
3000000.0
CY2020Q4 us-gaap Qualified Affordable Housing Project Investments Commitment
QualifiedAffordableHousingProjectInvestmentsCommitment
446000
CY2019Q4 us-gaap Qualified Affordable Housing Project Investments Commitment
QualifiedAffordableHousingProjectInvestmentsCommitment
798000
CY2020 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
229000
CY2019 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
229000
CY2020 efsi Affordable Housing Tax Creditsand Other Tax Benefits Expectedto Be Received
AffordableHousingTaxCreditsandOtherTaxBenefitsExpectedtoBeReceived
337000
CY2020 us-gaap Affordable Housing Tax Credits And Other Tax Benefits Amount
AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount
324000
CY2019 us-gaap Affordable Housing Tax Credits And Other Tax Benefits Amount
AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount
415000

Files In Submission

Name View Source Status
0001564590-21-016594-index-headers.html Edgar Link pending
0001564590-21-016594-index.html Edgar Link pending
0001564590-21-016594.txt Edgar Link pending
0001564590-21-016594-xbrl.zip Edgar Link pending
efsi-10k_20201231.htm Edgar Link pending
efsi-10k_20201231_htm.xml Edgar Link completed
efsi-20201231.xsd Edgar Link pending
efsi-20201231_cal.xml Edgar Link unprocessable
efsi-20201231_def.xml Edgar Link unprocessable
efsi-20201231_lab.xml Edgar Link unprocessable
efsi-20201231_pre.xml Edgar Link unprocessable
efsi-ex211_122.htm Edgar Link pending
efsi-ex231_181.htm Edgar Link pending
efsi-ex311_123.htm Edgar Link pending
efsi-ex312_121.htm Edgar Link pending
efsi-ex321_120.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ghimwrplslmi000001.jpg Edgar Link pending
gkww3oys2djr000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending